DanCann Pharma A/S, a biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas. It sources, develops, and distributes prescription and over-the-counter cannabinoid-based pharmaceuticals primarily focused on pain patients. The company's development pipeline includes EXT02 CannGros, EXT03 CannGros, EXT04 CannGros, FLS04 CannGros, and FLS05 CannGros. It is also involved in the import and distribution of Bedrocan CannGros, Bedica CannGros, and Bediol CannGros. The company was incorporated in 2018 and is based in Ansager, Denmark.
Apa simbol saham Danieli & C - Officine Meccaniche Spa?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Danieli & C - Officine Meccaniche Spa diperdagangkan dengan simbol DNIFY.
Berapa pendapatan Danieli & C - Officine Meccaniche Spa tahun lalu?▼
Pendapatan Danieli & C - Officine Meccaniche Spa tahun lalu berjumlah 14.42B USD.
Berapa pendapatan bersih Danieli & C - Officine Meccaniche Spa tahun lalu?▼
Pendapatan bersih DNIFY untuk tahun lalu adalah 424.79M USD.
Berapa jumlah karyawan Danieli & C - Officine Meccaniche Spa?▼
Per Mei 11, 2026, perusahaan memiliki 12 karyawan.
Danieli & C - Officine Meccaniche Spa berada di sektor apa?▼
Danieli & C - Officine Meccaniche Spa beroperasi di sektor Kesehatan & Kebugaran.